| Cheryl Hamilton, MD | |
|
600 Commerce Blvd, Suite 200, Stroudsburg, PA 18360-6214 | |
| (570) 426-2700 | |
| (570) 424-1252 |
| Full Name | Cheryl Hamilton |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 600 Commerce Blvd, Stroudsburg, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689787632 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 157207 (New York) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD423370 (Pennsylvania) | Primary |
| Entity Name | Family Care Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669563037 PECOS PAC ID: 5395649347 Enrollment ID: O20031121000497 |
News Archive
The Associated Press: "With just days remaining to prove that they can meet a self-imposed Christmas deadline and pass President Barack Obama's signature initiative through the Senate, Democrats seeking a rendezvous with history instead detoured to an intraparty brawl. ... All eyes were on the only known Democratic holdout, moderate Sen. Ben Nelson of Nebraska, whose primary concern is that abortion funding restrictions in the bill were too lax.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Vizioncore Inc. today announced the company is making a $500 donation to 26.2 with Donna - The National Marathon to Finish Breast Cancer. The charitable organization is the only U.S. marathon dedicated solely to raising funds to end breast cancer.
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
UC Davis researchers have discovered that a blood component linked with inflammation can predict coronary artery disease in African-Americans.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl Hamilton, MD 206 E Brown St, Pocono Healthcare Management - Professional Center, East Stroudsburg, PA 18301-3006 Ph: (570) 420-4951 | Cheryl Hamilton, MD 600 Commerce Blvd, Suite 200, Stroudsburg, PA 18360-6214 Ph: (570) 426-2700 |
News Archive
The Associated Press: "With just days remaining to prove that they can meet a self-imposed Christmas deadline and pass President Barack Obama's signature initiative through the Senate, Democrats seeking a rendezvous with history instead detoured to an intraparty brawl. ... All eyes were on the only known Democratic holdout, moderate Sen. Ben Nelson of Nebraska, whose primary concern is that abortion funding restrictions in the bill were too lax.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Vizioncore Inc. today announced the company is making a $500 donation to 26.2 with Donna - The National Marathon to Finish Breast Cancer. The charitable organization is the only U.S. marathon dedicated solely to raising funds to end breast cancer.
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
UC Davis researchers have discovered that a blood component linked with inflammation can predict coronary artery disease in African-Americans.
› Verified 6 days ago
Dr. Radhika Ailawadi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Commerce Blvd, Stroudsburg, PA 18360 Phone: 570-426-2700 Fax: 570-424-1252 |